# Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease

> **NCT03258294** · PHASE4 · UNKNOWN · sponsor: **KIMJisun** · enrollment: 82 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Melatonin(Circadin®)
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03258294
- **Lead sponsor:** KIMJisun
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01-13
- **Primary completion:** 2018-12-30
- **Final completion:** 2018-12-30
- **Target enrollment:** 82 (ESTIMATED)
- **Last updated:** 2017-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03258294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03258294, "Effect of Melatonin on Sleep Disturbances in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03258294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*